We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




OraSure Technologies to Purchase DNA Genotek for US$53 Million

By LabMedica International staff writers
Posted on 01 Aug 2011
Print article
OraSure Technologies, Inc. (Bethlehem, PA, USA) will acquire privately held DNA Genotek Inc. (Ottawa, Canada), a leading provider of oral fluid sample collection, stabilization, and preparation products for molecular diagnostic applications. The transaction valued at approximately US$53 million is anticipated to close in the third quarter of 2011.

The acquisition of DNA Genotek will strengthen OraSure’s leadership in oral fluid diagnostics, by providing a complementary portfolio of products that enable easy and reliable collection, stabilization, transportation, and storage of high quality nucleic acid (DNA and RNA) samples. These samples can then be used for a wide range of diagnostic and research applications.

The Oragene•DNA sample collection kit is DNA Genotek's lead product, providing an all-in-one system for the collection, stabilization, transportation and purification of DNA from saliva. Genetic samples are collected using a simple, noninvasive method; collected samples may be transported and stored for extended periods at ambient temperatures.

DNA Genotek products are used in clinical genetic testing, pharmacogenomics, personalized medicine, academic research, animal genetics, and livestock genetics markets. DNA Genotek is a leading provider of oral fluid collection devices to the direct-to-consumer personal genetics testing market. The company supplies products that provide substantial advantages over traditional methods of sampling such as blood or buccal swabs.

OraSure Technologies is a leader in the development, manufacture, and distribution of oral fluid diagnostic devices and other technologies designed to diagnose critical medical conditions and diseases. Its innovative products include rapid tests for the detection of antibodies to Human Immunodeficiency virus (HIV) and Hepatitis C virus (HCV) at the point of care (POC) and testing solutions for detecting various drugs of abuse.

OraSure’s products are sold globally to various clinical laboratories, hospitals, clinics, community-based organizations, and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities.

Related Links:

OraSure Technologies, Inc.
DNA Genotek Inc.


Gold Member
Turnkey Packaging Solution
HLX
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Hepatitis B Virus Test
HBs Ab – ELISA
New
Automatic Biochemistry Analyzer
Audmax 180 Evolution

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.